Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

CIBERESUCICOVID Project (COV20/00110, ISCIII); Victoria Alcaraz Serrano

doi:10.1016/j.jinf.2022.12.027

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

CIBERESUCICOVID Project (COV20/00110, ISCIII)
, Victoria Alcaraz Serrano

Facultat de Ciències de la Salut Blanquerna

Producció científica: Article en revista indexada › Carta › Avaluat per experts

4 Cites (Scopus)

Idioma original	Anglès
Pàgines (de-a)	282-286
Nombre de pàgines	5
Revista	Journal of Infection
Volum	86
Número	3
DOIs	https://doi.org/10.1016/j.jinf.2022.12.027
Estat de la publicació	Publicada - de març 2023

SDG de les Nacions Unides

Aquest resultat contribueix als següents objectius de desenvolupament sostenible.

ODS 3 Salut i benestar

Accés al document

10.1016/j.jinf.2022.12.027Llicència: Sense especificar

Altres arxius i enllaços

Com citar-ho

@article{1391aee861c24930b083df8c33c3f37c,

title = "Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study",

keywords = "COVID-19, Critically ill patients, Intensive care, Outcomes, Remdesivir",

author = "\{CIBERESUCICOVID Project (COV20/00110, ISCIII)\} and Catia Cill{\'o}niz and Anna Motos and Tatiana Casta{\~n}eda and Albert Gabarr{\'u}s and Ferran Barb{\'e} and Antoni Torres and Gumucio-Sanguino, \{V{\'i}ctor D.\} and Rafael Ma{\~n}ez and Jordi Sol{\'e}-Violan and \{de Castro\}, \{Felipe Rodr{\'i}guez\} and Fernando Suarez-Sipmann and Garc{\'i}a, \{Ruth Noem{\'i} Jorge\} and Aznar, \{Mar{\'i}a Mora\} and Mateu Torres and Mar{\'i}a Martinez and Cynthia Alegre and Jordi Riera and Sof{\'i}a Contreras and Pericas, \{Juan Manuel\} and Ricard Ferrer and Jes{\'u}s Caballero and Javier Trujillano and Montse Vallverd{\'u} and Miguel Le{\'o}n and Mariona Bad{\'i}a and Bego{\~n}a Balsera and Llu{\'i}s Servi{\`a} and Judit Vilanova and Silvia Rodr{\'i}guez and Neus Montserrat and Silvia Iglesias and Javier Prados and Sula Carvalho and Mar Miralb{\'e}s and Josman Monclou and Gabriel Jim{\'e}nez and Jordi Codina and Estela Val and Pablo Pagliarani and Jorge Rubio and Dulce Morales and Andr{\'e}s Pujol and {\`A}ngels Furro and Beatriz Garc{\'i}a and Gerard Torres and Javier Vengoechea and Calvo, \{David de Gozalo\} and Jessica Gonz{\'a}lez and Silvia Gomez and \{Alcaraz Serrano\}, Victoria",

note = "Funding Information: This study was supported by the Instituto de Salud Carlos III de Madrid ( COV20/00110 , ISCIII); Fondo Europeo de Desarrollo Regional (FEDER); {"}Una manera de hacer Europa{"}; and Centro de Investigaci{\'o}n Biom{\'e}dica En Red – Enfermedades Respiratorias (CIBERES). DdGC has received financial support from the Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041 ), co-funded by European Social Fund (ESF) / “Investing in your future”. CC received a grant from the Fondo de Investigaci{\'o}n Sanitaria ( PI19/00207 ), Instituto de Salud Carlos III, co-funded by the European Union. ",

year = "2023",

month = mar,

doi = "10.1016/j.jinf.2022.12.027",

language = "English",

volume = "86",

pages = "282--286",

journal = "Journal of Infection",

issn = "0163-4453",

publisher = "W.B. Saunders Ltd",

number = "3",

}

TY - JOUR

T1 - Remdesivir and survival outcomes in critically ill patients with COVID-19

T2 - A multicentre observational cohort study

AU - CIBERESUCICOVID Project (COV20/00110, ISCIII)

AU - Cillóniz, Catia

AU - Motos, Anna

AU - Castañeda, Tatiana

AU - Gabarrús, Albert

AU - Barbé, Ferran

AU - Torres, Antoni

AU - Gumucio-Sanguino, Víctor D.

AU - Mañez, Rafael

AU - Solé-Violan, Jordi

AU - de Castro, Felipe Rodríguez

AU - Suarez-Sipmann, Fernando

AU - García, Ruth Noemí Jorge

AU - Aznar, María Mora

AU - Torres, Mateu

AU - Martinez, María

AU - Alegre, Cynthia

AU - Riera, Jordi

AU - Contreras, Sofía

AU - Pericas, Juan Manuel

AU - Ferrer, Ricard

AU - Caballero, Jesús

AU - Trujillano, Javier

AU - Vallverdú, Montse

AU - León, Miguel

AU - Badía, Mariona

AU - Balsera, Begoña

AU - Servià, Lluís

AU - Vilanova, Judit

AU - Rodríguez, Silvia

AU - Montserrat, Neus

AU - Iglesias, Silvia

AU - Prados, Javier

AU - Carvalho, Sula

AU - Miralbés, Mar

AU - Monclou, Josman

AU - Jiménez, Gabriel

AU - Codina, Jordi

AU - Val, Estela

AU - Pagliarani, Pablo

AU - Rubio, Jorge

AU - Morales, Dulce

AU - Pujol, Andrés

AU - Furro, Àngels

AU - García, Beatriz

AU - Torres, Gerard

AU - Vengoechea, Javier

AU - Calvo, David de Gozalo

AU - González, Jessica

AU - Gomez, Silvia

AU - Alcaraz Serrano, Victoria

N1 - Funding Information: This study was supported by the Instituto de Salud Carlos III de Madrid ( COV20/00110 , ISCIII); Fondo Europeo de Desarrollo Regional (FEDER); "Una manera de hacer Europa"; and Centro de Investigación Biomédica En Red – Enfermedades Respiratorias (CIBERES). DdGC has received financial support from the Instituto de Salud Carlos III (Miguel Servet 2020: CP20/00041 ), co-funded by European Social Fund (ESF) / “Investing in your future”. CC received a grant from the Fondo de Investigación Sanitaria ( PI19/00207 ), Instituto de Salud Carlos III, co-funded by the European Union.

PY - 2023/3

Y1 - 2023/3

KW - COVID-19

KW - Critically ill patients

KW - Intensive care

KW - Outcomes

KW - Remdesivir

UR - https://www.scopus.com/pages/publications/85149427738

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000949366700012

U2 - 10.1016/j.jinf.2022.12.027

DO - 10.1016/j.jinf.2022.12.027

M3 - Letter

C2 - 36596315

AN - SCOPUS:85149427738

SN - 0163-4453

VL - 86

SP - 282

EP - 286

JO - Journal of Infection

JF - Journal of Infection

IS - 3

ER -